Matthew Charles Mulvey

Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD.

MediBeacon, Inc. provides optical diagnostic products and services. It offers Optical Renal Function Monitor, a platform focused on kidney function monitoring in real-time at the point-of-care. The company was founded by Steven J. Hanley and Richard B. Dorshow in 2012 and is headquartered in St. Louis, MO.

Triple Ring Technologies, Inc. operates as an imaginative research and development firm. It works across the development process in regulated markets including medical devices, in vitro diagnostics and life science tools, imaging and industrial applications. The company was founded in February 2005 and is headquartered in Newark, CA.

R2 Technologies, Inc. is an American California-based company founded in 2014 by Irina Erenburg. The company specializes in developing groundbreaking technology that fights inflammation and provides precision cold treatment for the face and skin. The company's technology has been proven effective and is available for use in medical practices. The CEO is Tim Holt.